Get trade alerts

Medline ($MDLN) Insider Trading & Smart Money Activity

Medline Inc. · Medical Instruments & Supplies · Latest filing Oct 9, 2026

Medline Inc. ($MDLN) has 11 insider trades, 5 13F position changes and 2 analyst ratings on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($996.41M), net -$996.41M.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
1
Net insider $ (12 mo)
-$996.41M
Congress trades (12 mo)
0
13F moves on file
5
Analyst ratings on file
2

MDLN insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 0 / 0 3 / 2
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 4 · $996.41M 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All MDLN insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Analyst Barclays Reiterates to Overweight PT $43 -0.8% Read
Insider GIC Private Ltd10% Owner Sell (Open-market sale) 7.82M sh $274.77M +2.3% —
Insider GIC Private Ltd10% Owner Sell (Open-market sale) 9.27M sh $324.98M +0.4% —
Insider GIC Private Ltd10% Owner Sell (Open-market sale) 1.69M sh $60.42M -0.1% —
Insider GIC Private Ltd10% Owner Sell (Open-market sale) 9.72M sh $336.24M +1.8% —
Analyst UBS Reiterates to Buy PT $43 +2.6% —
Insider Douglas GolwasChief Commercial Officer Sell (Disposition to issuer) 100K sh -4.8%+10.8% —
Insider Douglas GolwasChief Commercial Officer Buy (Option exercise) 100K sh -4.8%+10.8% —
Insider Christopher ShryockChief Human Resources Officer Sell (Tax withholding) 872 sh $31.92K -7.0%+5.7% —
Insider Stephen MillerChief Operating Officer Sell (Tax withholding) 1.89K sh $69.16K -7.0%+5.7% —
Insider Amanda LaabsChief Product Officer Sell (Tax withholding) 1.89K sh $69.16K -7.0%+5.7% —
Insider James BoyleChief Executive Officer Sell (Tax withholding) 2.37K sh $86.77K -7.0%+5.7% —
Insider Thomas Sweet Buy (Grant or award) 5.39K sh -3.2%+9.3% Read
13F Viking Global Investors Added +4.47M sh $450.96M +2.3%+3.2% —
13F Viking Global Investors Added +4.47M sh $424.54M +2.3%+3.2% —
13F Pentwater Capital Management New +50K sh $1.97M +2.3%+3.2% Read
13F Wcm Investment Management Reduced -105.85K sh $284.71M -7.1%-19.3% —
13F Wcm Investment Management Reduced -105.85K sh $268.03M -7.1%-19.3% —

1W / 1M / 6M = how MDLN moved from the trade or filing date.

Insider trading in MDLN: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
GIC Private Ltd 10% Owner 4 -$996.41M Oct 8, 2026
Douglas Golwas Chief Commercial Officer 2 — Jun 16, 2026
Christopher Shryock Chief Human Resources Officer 1 — Jun 15, 2026
Stephen Miller Chief Operating Officer 1 — Jun 15, 2026
Amanda Laabs Chief Product Officer 1 — Jun 15, 2026
James Boyle Chief Executive Officer 1 — Jun 15, 2026
Thomas Sweet 1 — Jun 11, 2026

Institutions moving MDLN (13F)

Analyst ratings on MDLN

DateFirmActionRatingPrice target1W1M6MStory
Barclays Reiterates Overweight $45 → $43 -0.8% Read
UBS Reiterates Buy $45 → $43 +2.6% —

Frequently asked questions

Are MDLN insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 4 open-market sales worth $996.41M, a net -$996.41M.

What is the latest insider trade in MDLN?

GIC Private Ltd, 10% Owner filed a sell (open-market sale) of 7.82M sh worth $274.77M on Oct 8, 2026.

Which institutions changed their MDLN positions?

Recent 13F filers moving the stock include Viking Global Investors, Wcm Investment Management and Pentwater Capital Management.

Other medical instruments & supplies stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text